Clinic
Mcfarland Clinic PC
Mcfarland Clinic PC was paid $26.67M by Medicaid between Jan 2018 and Dec 2024, across 252 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 26% of everything it billed.
33Billing provider infoMCFARLAND CLINIC PC
AMES, IA 50010
AMES, IA 50010
33aNPI1639135643assigned 04/26/2006
33bProvider typeMulti-Specialty Clinic/Center
28Total paid$26.67M
24GClaims887,467
24DCodes billed252
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Multi-Specialty Clinic/Center providers in Iowa
Rank by total paid#1 of 10
Median peer was paid$48K
This provider vs. median559×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 102,924 | $3.33M | |
| 2019 | 113,077 | $3.76M | |
| 2020 | 93,263 | $3.13M | |
| 2021 | 137,164 | $4.27M | |
| 2022 | 157,594 | $4.69M | |
| 2023 | 154,961 | $4.15M | |
| 2024incomplete | 128,484 | $3.34M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 26% | 207,800 | 190,821 | $7.03M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 17% | 102,970 | 93,589 | $4.60M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 6.5% | 42,105 | 40,758 | $1.72M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.7% | 13,075 | 12,630 | $1.52M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 4.8% | 16,423 | 15,831 | $1.27M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.4% | 11,632 | 11,470 | $897K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.0% | 11,648 | 10,802 | $800K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 2.8% | 14,211 | 13,778 | $754K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.8% | 6,873 | 5,392 | $489K |
| J0475 | Injection, baclofen, 10 mg | 1.8% | 876 | 852 | $484K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.8% | 6,195 | 6,089 | $470K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.3% | 4,619 | 4,470 | $349K |
240 more codes
| 71046 | Radiologic examination, chest; 2 views | 1.2% | 22,885 | $318K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.2% | 3,645 | $307K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 1.1% | 2,751 | $290K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 2,739 | $239K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 3,586 | $231K |
| 96127 | <1% | 6,533 | $221K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 1,377 | $189K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 2,102 | $188K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 11,063 | $183K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 3,998 | $172K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 2,021 | $149K |
| 88142 | <1% | 6,081 | $140K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 14,981 | $136K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 8,302 | $130K |
| 90461 | <1% | 16,242 | $130K | |
| 90686 | <1% | 25,880 | $129K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 1,638 | $117K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 217 | $112K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 4,277 | $111K |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 9,222 | $109K |
| 36415 | Collection of venous blood by venipuncture | <1% | 40,937 | $106K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 2,358 | $97K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 6,358 | $97K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 2,824 | $93K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 5,574 | $89K |
| 11721 | <1% | 6,363 | $86K | |
| 73630 | <1% | 5,528 | $84K | |
| 88307 | <1% | 758 | $83K | |
| T1013 | Sign language or oral interpretive services, per 15 minutes | <1% | 2,908 | $75K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,965 | $73K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 7,835 | $71K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 9,378 | $67K |
| 92567 | <1% | 3,829 | $65K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,480 | $62K |
| 80053 | Comprehensive metabolic panel | <1% | 5,498 | $59K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 5,250 | $58K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 1,767 | $56K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 2,948 | $52K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 998 | $50K |
| 71045 | Radiologic examination, chest; single view | <1% | 7,911 | $48K |
| 99460 | <1% | 755 | $45K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 209 | $44K |
| 20610 | <1% | 839 | $42K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 765 | $37K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 207 | $37K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 346 | $35K |
| 73610 | <1% | 2,232 | $33K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 184 | $33K |
| 80061 | Lipid panel | <1% | 2,250 | $31K |
| 87081 | <1% | 3,796 | $29K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 479 | $24K |
| 99223 | Prolong inpt eval add15 m | <1% | 238 | $23K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 302 | $23K |
| 95117 | <1% | 1,693 | $23K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 356 | $21K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 441 | $20K |
| 90480 | <1% | 789 | $20K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 540 | $19K |
| 0071A | <1% | 478 | $19K | |
| 73560 | <1% | 1,308 | $19K | |
| 95811 | <1% | 127 | $18K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 376 | $18K |
| S0280 | Medical home program, comprehensive care coordination and planning, initial plan | <1% | 368 | $17K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 943 | $17K |
| 95990 | <1% | 564 | $16K | |
| 0072A | <1% | 391 | $16K | |
| 80050 | General health panel | <1% | 375 | $15K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 117 | $15K |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | <1% | 276 | $15K |
| 73110 | <1% | 861 | $14K | |
| 90961 | <1% | 412 | $13K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 160 | $13K |
| 95251 | <1% | 249 | $13K | |
| 73030 | <1% | 804 | $13K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,709 | $11K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 203 | $11K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 716 | $11K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 191 | $10K |
| 84439 | <1% | 1,135 | $10K | |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | <1% | 130 | $9K |
| 96367 | <1% | 356 | $9K | |
| 0001A | <1% | 258 | $9K | |
| 90670 | <1% | 5,822 | $9K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 2,512 | $9K |
| 74019 | <1% | 594 | $9K | |
| 0002A | <1% | 232 | $9K | |
| 00170 | Anesthesia for intraoral procedures, including biopsy | <1% | 37 | $9K |
| 3074F | <1% | 70,275 | $8K | |
| 90656 | <1% | 2,021 | $8K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 222 | $8K |
| 73130 | <1% | 546 | $8K | |
| 62323 | <1% | 50 | $7K | |
| 90651 | <1% | 344 | $7K | |
| 0012A | <1% | 197 | $7K | |
| 74018 | <1% | 431 | $7K | |
| 88141 | <1% | 280 | $6K | |
| 83655 | <1% | 362 | $6K | |
| 86140 | <1% | 926 | $6K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 121 | $6K |
| 0011A | <1% | 200 | $6K | |
| 76830 | Ultrasound, transvaginal | <1% | 103 | $5K |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 385 | $5K |
| 72100 | <1% | 299 | $5K | |
| 3078F | <1% | 32,010 | $5K | |
| 95024 | <1% | 124 | $5K | |
| 87581 | <1% | 112 | $5K | |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 17 | $5K |
| 31231 | <1% | 66 | $5K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 80 | $4K |
| 91321 | <1% | 154 | $4K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 95 | $4K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 97 | $4K |
| 20553 | <1% | 106 | $4K | |
| 87631 | <1% | 51 | $4K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 52 | $4K |
| 92015 | Determination of refractive state | <1% | 275 | $4K |
| 73562 | <1% | 218 | $4K | |
| 83735 | <1% | 527 | $3K | |
| 96161 | <1% | 488 | $3K | |
| 92551 | <1% | 244 | $3K | |
| 54150 | <1% | 36 | $3K | |
| 99462 | <1% | 106 | $3K | |
| 90619 | <1% | 143 | $3K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 44 | $3K |
| 90734 | <1% | 168 | $3K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 483 | $3K |
| 92134 | <1% | 176 | $3K | |
| 67028 | Intravitreal injection of a pharmacologic agent | <1% | 29 | $3K |
| 87807 | <1% | 191 | $3K | |
| 73502 | <1% | 167 | $3K | |
| 95991 | <1% | 68 | $3K | |
| 0054A | <1% | 73 | $3K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 64 | $3K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 63 | $3K |
| 88304 | <1% | 98 | $3K | |
| 93000 | <1% | 145 | $3K | |
| 94060 | <1% | 78 | $3K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 151 | $3K |
| 73140 | <1% | 189 | $3K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 50 | $2K |
| 85651 | <1% | 525 | $2K | |
| V2020 | Frames, purchases | <1% | 93 | $2K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 39 | $2K |
| 01967 | Neuraxial labor analgesia/anesthesia for planned vaginal delivery | <1% | 12 | $2K |
| 85018 | <1% | 694 | $2K | |
| 99381 | <1% | 36 | $2K | |
| 62370 | <1% | 29 | $2K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 97 | $2K |
| 31575 | <1% | 25 | $2K | |
| 90677 | <1% | 572 | $2K | |
| 0124A | <1% | 56 | $2K | |
| 99152 | <1% | 137 | $1K | |
| 99188 | <1% | 98 | $1K | |
| 11102 | <1% | 25 | $1K | |
| 80069 | <1% | 151 | $1K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 12 | $1K |
| 90685 | <1% | 684 | $1K | |
| 94010 | <1% | 64 | $1K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 28 | $1K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 75 | $1K |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 48 | $1K |
| 85027 | <1% | 130 | $1K | |
| 99385 | <1% | 12 | $1K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 59 | $1K |
| 76801 | <1% | 12 | $999.96 | |
| 85652 | <1% | 288 | $981.30 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 256 | $933.86 |
| 3079F | <1% | 2,495 | $900.00 | |
| 0064A | <1% | 25 | $852.80 | |
| 90633 | <1% | 759 | $782.32 | |
| 90710 | <1% | 38 | $769.55 | |
| 97162 | <1% | 13 | $745.78 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 136 | $744.74 |
| L4361 | Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated, off-the-shelf | <1% | 12 | $738.40 |
| 99307 | <1% | 36 | $721.89 | |
| 86738 | <1% | 49 | $687.13 | |
| 76536 | <1% | 13 | $610.83 | |
| 92250 | <1% | 108 | $606.75 | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 12 | $599.54 |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 12 | $590.57 |
| 82728 | <1% | 40 | $576.14 | |
| 90717 | <1% | 15 | $535.90 | |
| 0004A | <1% | 14 | $528.00 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 43 | $515.51 |
| 69210 | <1% | 12 | $472.86 | |
| 90715 | <1% | 43 | $426.39 | |
| 90698 | <1% | 2,055 | $366.10 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 39 | $362.01 |
| 0081A | <1% | 14 | $323.20 | |
| 87510 | <1% | 12 | $322.42 | |
| 87480 | <1% | 12 | $322.42 | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 14 | $319.54 |
| 87660 | <1% | 12 | $316.33 | |
| 90697 | <1% | 349 | $304.28 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 336 | $272.82 |
| 82570 | <1% | 55 | $261.18 | |
| V2103 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | <1% | 12 | $256.88 |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | <1% | 12 | $250.98 |
| 0154A | <1% | 12 | $242.40 | |
| 81001 | <1% | 50 | $225.08 | |
| 83550 | <1% | 26 | $211.79 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 12 | $209.36 |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | <1% | 12 | $203.15 |
| 80076 | <1% | 24 | $188.65 | |
| 83540 | <1% | 26 | $181.62 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 14 | $160.17 |
| 82565 | <1% | 24 | $132.96 | |
| 80047 | <1% | 12 | $131.91 | |
| 93296 | <1% | 12 | $125.87 | |
| 86431 | <1% | 15 | $111.03 | |
| 90744 | <1% | 510 | $109.58 | |
| 90680 | <1% | 3,040 | $93.00 | |
| 81003 | <1% | 31 | $89.56 | |
| 84156 | <1% | 14 | $63.95 | |
| V2756 | Eye glass case | <1% | 67 | $60.48 |
| 90648 | <1% | 12 | $55.52 | |
| 99310 | Prolong nursin fac eval 15m | <1% | 17 | $52.36 |
| 82043 | <1% | 15 | $49.48 | |
| 85014 | <1% | 12 | $36.93 | |
| 3044F | <1% | 44 | $20.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 29 | $9.46 |
| 0502F | <1% | 5,090 | $0.01 | |
| 99024 | 0% | 764 | $0.00 | |
| 91307 | 0% | 1,109 | $0.00 | |
| 3075F | 0% | 117 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 137 | $0.00 |
| 91301 | 0% | 389 | $0.00 | |
| 91305 | 0% | 155 | $0.00 | |
| 91306 | 0% | 13 | $0.00 | |
| 90716 | 0% | 41 | $0.00 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 18 | $0.00 |
| 91315 | 0% | 12 | $0.00 | |
| 90696 | 0% | 12 | $0.00 | |
| 91300 | 0% | 716 | $0.00 | |
| 91312 | 0% | 40 | $0.00 | |
| 90707 | 0% | 27 | $0.00 | |
| 91308 | 0% | 105 | $0.00 | |
| 90700 | 0% | 27 | $0.00 | |
| 90662 | 0% | 33 | $0.00 | |
| 99177 | 0% | 19 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPERRY, ANDREW (CEO)